Chiome Bioscience Inc. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY61.6 |
Market Cap |
JPY7.41 B |
Shares Outstanding |
32.77 M |
Public Float |
24.59 M |
Address |
Sumitomo Fudosan Nishi-Shinjuku Bldg Tokyo Tokyo 151 Japan |
Employees | - |
Website | http://www.chiome.co.jp |
Updated | 07/08/2019 |
Chiome Bioscience, Inc. engages in the manufacture and sale of antibody drugs through the Autonomous Diversifying Library (ADLib) System. Its operations are carried out through Innovative Drug and Innovative Drug Support business segments. The Innovative Drug segment manufactures specific antibodies based on new antigen mechanisms and licenses these out to pharmaceutical industries. |